Clinical Study Results
Research Sponsor: AstraZeneca
Drug Studied: Olaparib
Study Title: A study to learn how olaparib works and about its
safety in men with metastatic castration-resistant
prostate cancer compared with enzalutamide
and abiraterone acetate
Thank you!
Thank you for taking part in the clinical study for the study drug olaparib.
You and all of the participants helped researchers learn more about olaparib to help men with
metastatic castration-resistant prostate cancer.
AstraZeneca sponsored this study and believes it is important to share the results of the study
with you and the public. An independent non-profit organization called CISCRP helped prepare
this summary of the study results for you. We hope it helps you understand and feel proud of
your important role in medical research.
If you participated in the study and have questions about the results, please speak with the
study doctor or staff at your study site.
1